Natus Medical (BABY) Misses Q4 EPS by 2c

Go back to Natus Medical (BABY) Misses Q4 EPS by 2c

Raymond James Downgrades Natus Medical (BABY) to Market Perform

February 2, 2017 7:48 AM EST

Raymond James downgraded Natus Medical (NASDAQ: BABY) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Natus Medical click here. For more ratings news on Natus Medical click here.

Shares of Natus Medical closed at $36.60 yesterday.

... More